Image

    Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses

    June 2026 in “ Dermato ”
    Giuseppe Lauletta, Luca Potestio, Paola Nappa, Maddalena Napolitano
    Studysummary This narrative review found that ritlecitinib shows consistent effectiveness and a favorable safety profile for treating alopecia areata in clinical trials and real-world settings, with progressive hair regrowth observed, particularly when treatment is initiated early and maintained appropriately.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 22

    1. Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real-World Experience International Journal of Dermatology · 2026
    2. Ritlecitinib in Alopecia Areata: A 24-Week Real-World Experience Contrasting JAK Inhibitor-Naïve and JAK Inhibitor-Experienced Patients The Journal of Dermatology · 2025
    3. Sustaining Treatment Response in Alopecia Areata Through Tofacitinib Dose Tapering: A Single-Center Retrospective Study Journal of the American Academy of Dermatology · 2025
    4. Evaluating Current and Emerging JAK Inhibitors for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025
    5. Safety of Oral JAK Inhibitors in Treating Alopecia Areata: A Systematic Review and Network Meta-Analysis Frontiers in Pharmacology · 2025
    6. Real-World Assessment of Ritlecitinib in Patients with Severe Alopecia Areata: A 24-Week Multicentre Retrospective Study Clinical and Experimental Dermatology · 2025
    7. SALT Score Distribution With Ritlecitinib Treatment Up to 24 Months in Alopecia Areata Journal of the European Academy of Dermatology and Venereology · 2025
    8. Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials Journal of Clinical Medicine · 2025
    9. Effectiveness and Tolerability of Ritlecitinib in Children With Alopecia Areata: A Case Series Journal of the American Academy of Dermatology · 2025
    10. Systematic Review and Indirect Treatment Comparisons of Ritlecitinib Against Baricitinib in Alopecia Areata Journal of the European Academy of Dermatology and Venereology · 2024
    11. Impact of Previous Alopecia Areata Treatment on Efficacy Responses Up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis Dermatology and Therapy · 2024
    12. European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2024
    13. Alopecia Areata: What's New in the Epidemiology, Comorbidities, and Pathogenesis? Journal of Dermatological Science · 2023
    14. Alopecia Areata: Current Treatments and New Directions American Journal of Clinical Dermatology · 2023
    15. Ritlecitinib: First Approval Drugs · 2023
    16. Janus Kinase Inhibitors for Alopecia Areata Journal of the American Academy of Dermatology · 2023
    17. Alopecia Areata: An Updated Review for 2023 Journal of Cutaneous Medicine and Surgery · 2023
    18. Quality of Life in Children and Adolescents With Alopecia Areata: A Systematic Review Journal of the European Academy of Dermatology and Venereology · 2023
    19. An Overview of JAK/STAT Pathways and JAK Inhibition in Alopecia Areata Frontiers in immunology · 2022
    20. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata Drug Design Development and Therapy · 2022
    21. Alopecia Areata: An Update on Etiopathogenesis, Diagnosis, and Management Clinical Reviews in Allergy & Immunology · 2021
    22. Alopecia Areata: Overview and Insights from January 2018 Journal of The American Academy of Dermatology · 2017